These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 6409665

  • 1. Action of dihydroergocristine on enzyme activities related to energy transduction.
    Gorini A, Villa RF.
    Farmaco Prat; 1983 May; 38(5):191-9. PubMed ID: 6409665
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Blood prolactin-lowering activity of dihydroergocristine].
    Cocchi D, Müller EE, Boselli P, Faini D.
    Farmaco Sci; 1985 Jul; 40(7):534-40. PubMed ID: 3930286
    [Abstract] [Full Text] [Related]

  • 4. [Alpha-blocking activity of raubasine-dihydroergocristine combination in the demedullated rat].
    Roquebert J, Gomond P, Demichel P.
    Ann Pharm Fr; 1983 Jul; 41(1):69-75. PubMed ID: 6137989
    [No Abstract] [Full Text] [Related]

  • 5. Dihydroergocristine improves behavioral deficits of aged rats.
    D'Agata V, Spadaro F, Drago F.
    Pharmacol Res Commun; 1988 Dec; 20(12):1119-20. PubMed ID: 3145509
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Action of dihydroergocristine at pre- and postsynaptic alpha-adrenoceptors in the rat isolated vas deferens].
    Roquebert J, Demichel P, Gomond P, Malek A.
    J Pharmacol; 1983 Dec; 14(2):151-9. PubMed ID: 6134866
    [Abstract] [Full Text] [Related]

  • 8. Influence of some ergot alkaloids on the cerebral reduced glutathione.
    Gorini A, Arnaboldi R, Vercesi L, Dossena M.
    Farmaco Sci; 1988 Nov; 43(11):887-90. PubMed ID: 3150835
    [Abstract] [Full Text] [Related]

  • 9. A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline.
    Barzaghi F, Dragonetti M, Formento ML, Gueniau C, Nencioni A, Mantegazza P.
    Arzneimittelforschung; 1986 Oct; 36(10):1442-8. PubMed ID: 3814205
    [Abstract] [Full Text] [Related]

  • 10. [In vivo antiaggregant activity of dihydroergotoxine].
    Manzanares J, Zaragozá F, Benedí J, Iglesias I.
    Arch Farmacol Toxicol; 1986 Oct; 12(2-3):139-44. PubMed ID: 3619502
    [No Abstract] [Full Text] [Related]

  • 11. Synergistic interactions between piracetam and dihydroergocristine in some animal models of cerebral hypoxia and ischaemia.
    Berga P, Beckett PR, Roberts DJ, Llenas J, Massingham R.
    Arzneimittelforschung; 1986 Sep; 36(9):1314-20. PubMed ID: 3098253
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of norepinephrine- and 5-hydroxytryptamine-induced contraction on rat aorta by dihydroergocristine.
    D'Agostino G, Dondi G, Zonta F, Grana E.
    Farmaco Sci; 1984 Mar; 39(3):208-16. PubMed ID: 6425080
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of voluntary ethanol intake in rats by a combination of dihydroergotoxine and thioridazine.
    Fadda F, Franch F, Mosca E, Meloni R, Gessa GL.
    Alcohol Drug Res; 1987 Mar; 7(4):285-90. PubMed ID: 3828005
    [Abstract] [Full Text] [Related]

  • 14. Dihydroergocristine. Recent research and development.
    Mailland F.
    Arzneimittelforschung; 1992 Nov; 42(11A):1379-80. PubMed ID: 1492856
    [No Abstract] [Full Text] [Related]

  • 15. The effect of dihydroergotoxine on the adenylate cyclase activity in homogenates of rat cerebral cortex.
    Sundquist H, Anttila M, Nieminen L, Urpo K, Kalliomäki.
    Acta Pharmacol Toxicol (Copenh); 1977 May; 40(5):589-92. PubMed ID: 194460
    [No Abstract] [Full Text] [Related]

  • 16. Effects of the new eburnamenine derivative RU 24722 on EEG recovery and cerebral energy metabolism after complete ischemia.
    Barzaghi F, Dragonetti M, Formento ML, Boissier JR.
    Arzneimittelforschung; 1985 May; 35(2):472-7. PubMed ID: 4039569
    [Abstract] [Full Text] [Related]

  • 17. Actions and interactions of ergotamine and dihydroergocristine in rat aortic strips.
    Grana E, D'Agostino G, Zonta F, Lucchelli A.
    Farmaco Sci; 1981 May; 36(5):334-43. PubMed ID: 6786918
    [Abstract] [Full Text] [Related]

  • 18. Dihydroergotoxine and the Seizure Threshold.
    Pericić D.
    Int Pharmacopsychiatry; 1981 May; 16(1):10-20. PubMed ID: 7298268
    [Abstract] [Full Text] [Related]

  • 19. [Dihydroergocristine. Recent research and development].
    Arzneimittelforschung; 1992 Nov; 42(11A):1379-421. PubMed ID: 1492855
    [No Abstract] [Full Text] [Related]

  • 20. The effect of hydergine on cyclosporine-induced nephrotoxicity in kidney allografted rats.
    Ijzermans JN, Singh SK, de Bruin RW, Bouwman E, Weimar W, Marquet RL, Jeekel J.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1385-6. PubMed ID: 3274337
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.